Pan-cancer analysis predicts MBOAT2 as a potential new ferroptosis related gene immune checkpoint
MBOAT2 holds promise as a prognostic biomarker and may serve as a target for immunotherapy in various malignancies. Further investigation into its role in cancer immunity could offer new insights into potential therapeutic strategies.
Authors
- Shiyong Qi (ORCID: https://orcid.org/0009-0004-5967-8075)
- Xiuju Chen (ORCID: https://orcid.org/0000-0002-9233-9567)
- Yu Wu (ORCID: https://orcid.org/0000-0002-1321-5014)
- Yuhan Xie (ORCID: https://orcid.org/0009-0000-2846-6556)
- Bing Chen (ORCID: https://orcid.org/0000-0002-0026-1249)
- Shichao Zhang (ORCID: https://orcid.org/0000-0001-9981-2970)
- Yuanjiong Qi (ORCID: https://orcid.org/0000-0002-2331-2205)
Institutions
- Tianjin Nankai Hospital (CN)
- Second Hospital of Tianjin Medical University (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1007/s12672-025-02078-1
- Citations
- 2
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.04